Domschke, Katharina
Zwanzger, Peter
Funding for this research was provided by:
Universitätsklinikum Freiburg
Article History
Accepted: 28 April 2025
First Online: 29 July 2025
Declarations
:
: K. Domschke and P. Zwanzger are board members of the German Society of Psychiatry (DGPPN) and the German Society of Anxiety Research (GAF). Additionally, K. Domschke is a board member of the Lundbeck Foundation “Neurotorium” and the Freiburg Institute of Behavioral Therapy (FAVT) and has received speaker’s honoraria by Janssen Cilag. Over the last 3 years, P. Zwanzger has received speaker fees or honoraria for advisory board participation from Janssen Cilag/Johnson & Johnson, Schwabe, Sympatient, GAIA, MagVenture, Boehringer, Idorsia, and Neuraxpharm.
: For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.
: The supplement containing this article is not sponsored by industry.